Respiratory illnesses like influenza, COVID-19 and respiratory syncytial virus (RSV) are leading to many people being ...
Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...
Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...
In the throes of winter's yearly round of respiratory virus outbreaks, it pays to remember what Grandma told you.
It’s what’s being called a “Quad-demic,” with cases on the rise for COVID-19, Respiratory syncytial virus (RSV), Influenza, ...
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...
It appears RSV and COVID have peaked, but the flu is still rising. The number and rate of positive cases of COVID is notably ...
Respiratory illnesses like influenza, COVID-19 and respiratory syncytial virus (RSV) are leading to many people being ...
A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.
Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t ...